Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.
Techstars helps founders scale their startups into world-changing businesses.
Founded in 2006, Techstars is on a mission to invest in startups to enable more capital to flow to more entrepreneurs around the world in order to deliver exceptional returns to our investors. We do this by operating accelerator programs and venture capital funds, as well as by connecting startups, investors, corporations, and cities to help build thriving startup communities.
Our results show why Techstars is Better for Founders than any other global accelerator: On average, 74.5% of Techstars companies will raise money within 3 years of their program; 18.5% of Techstars portfolio companies have exited 5 years after their program and 31.1% after eight years. (PitchBook June 2023)
Delve is a product innovation services firm. We partner with ambitious teams to bring step change innovations to market in industries where the challenges are simultaneously complex, constrained, and consequential. By blending breakthrough creativity with rigorous de-risking and a deep focus on organizational alignment, we help our clients define, envision, and develop innovations that deliver real business impact.
Delve operates studios in Boston, Madison, Philadelphia, and San Francisco, and partners with leading companies including GE HealthCare, Google, Johnson & Johnson, Kohler, P&G, and Stryker. Learn more at Delve.com.